Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.

被引：0
|
作者：
Steén, B
Sarman, S
Fagerholm, P
Kvanta, A
机构：
[1] St Eriks Eye Hosp, Dept Ophthalmol, Stockholm, Sweden
[2] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4423B370
引用
收藏
页码：S833 / S833
页数：1
相关论文
共 50 条
  • [1] Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization
    Kvanta, A
    Sarman, S
    Fagerholm, P
    Seregard, S
    Steen, B
    EXPERIMENTAL EYE RESEARCH, 2000, 70 (04) : 419 - 428
  • [2] Expression of vascular endothelial growth factor (VEGF) in a rat model of inflammation-associated corneal neovascularization
    Kvanta, A
    Sarman, S
    Seregard, S
    Steen, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S97 - S97
  • [3] Recombinant EXM, a noncatalytic fragment of matrix metalloproteinase-2 (MMP-2), inhibits corneal neovascularization
    Friedlander, M
    Aguilar, E
    Gigliotti, B
    Leonard, M
    Dorrell, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S194 - S194
  • [4] Effect of vascular endothelial growth factor (VEGF) on the corneal neovascularization and expression of MMP-2, 9, TIMP-1, 2 and flk-1.
    Lee, JB
    Jung, SE
    Park, HY
    Hong, BK
    Kwon, HM
    Kim, EK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S479 - S479
  • [5] Reduced choroidal neovascularization in matrix metalloproteinase-2 (MMP-2) deficient mice
    Berglin, LC
    Sarman, S
    Seregard, S
    van der Ploeg, I
    Kvanta, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U293 - U293
  • [6] Role of matrix metalloproteinase-2 (MMP-2) and PEX, a noncatalytic fragment of MMP-2, in corneal angiogenesis
    Aguilar, E
    Gigliotti, B
    Bersaglieri, T
    Leonard, M
    Cheresh, D
    Friedlander, M
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 167A - 167A
  • [7] Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression
    Reddy, Ramakkamma Aishwarya
    Varshini, Magham Sai
    Kumar, Raman Suresh
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2025, 20 (01) : 26 - 44
  • [8] Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas
    Ramachandran, Rahimsan K.
    Sorensen, Mia D.
    Aaberg-Jessen, Charlotte
    Hermansen, Simon K.
    Kristensen, Bjarne W.
    PLOS ONE, 2017, 12 (02):
  • [9] Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
    A Talvensaari-Mattila
    P Pääkkö
    T Turpeenniemi-Hujanen
    British Journal of Cancer, 2003, 89 : 1270 - 1275
  • [10] Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
    Talvensaari-Mattila, A
    Pääkkö, P
    Turpeenniemi-Hujanen, T
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1270 - 1275
12345